Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy.
J Allergy Clin Immunol
; 141(3): 1002-1008, 2018 03.
Article
in En
| MEDLINE
| ID: mdl-28870463
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Plant Proteins
/
Rhinitis, Allergic, Seasonal
/
Antigens, Plant
/
Sublingual Immunotherapy
/
Food Hypersensitivity
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Allergy Clin Immunol
Year:
2018
Type:
Article
Affiliation country:
Austria